
Italy · Medical devices startup
Newronika S.p.A. is an Italian medical technology company founded in 2008, with a focus on developing advanced adaptive deep brain stimulation (aDBS) therapies and neural devices.
Funding reportedLast round: Grant
Follow Newronika S.p.A. and see its new rounds in your feed.Start following
Newronika S.p.A. is an Italian medical technology company founded in 2008, with a focus on developing advanced adaptive deep brain stimulation (aDBS) therapies and neural devices.
Established as a joint venture between the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan, Newronika aims to restore brain and body functions for patients with neurological disorders, particularly Parkinson's disease. The company's flagship product, the AlphaDBS system, is a closed-loop device that learns from brain activity in real time, adjusting therapy to meet individual patient needs. This innovative system is designed to manage Parkinson’s disease symptoms effectively. Additionally, Newronika offers WebBioBank, an online platform that allows healthcare professionals to analyze biosignals and connect with patients. With a dedicated team of neuroscientists, biomedical engineers, and clinicians, Newronika is committed to improving patient quality of life through precise brain stimulation and has received FDA approval to begin pivotal trials for its adaptive DBS system.
Funding, as reported
From Newronika S.p.A.'s own website: 1 founder, 6 on the team.
AdvisersRoshini Jain
What they build
Known for
health caredigital healthclosed-loop systemclosedloop neurostimulationmedical equipment manufacturinginformation technology & servicesadaptive deep brain stimulationtelemedicinebiosignal interpretationclinical researchhospital & health careneuroscience research toolscloud data collectionclinical neuromodulationdeep brain stimulationhealth
Built with from their website
Amazon CloudFrontMarkforgedWordPress.orgApacheYouTubeCloudFlareRainViewport MetaGoogle DriveWebflow Hosting
CloudFlare CDNCAPTCHAGoogle Font APIMicrosoft ExchangeAdaMySQLMicrosoft 365 Apps & ServicesMobile Friendly
Add your raise, your deck and your story, and put Newronika S.p.A. in front of investors. Or tell us what we have wrong.